- CA$19.57m
- CA$10.56m
- CA$18.84m
- 80
- 60
- 30
- 57
2018 December 31st | 2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11.6 | 12.9 | 15.1 | 17.2 | 18.8 |
Cost of Revenue | |||||
Gross Profit | 6.14 | 5.45 | 7.62 | 10.5 | 11 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12.1 | 13.5 | 13 | 14.1 | 13.5 |
Operating Profit | -0.521 | -0.587 | 2.12 | 3.1 | 5.31 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.921 | -1.14 | 1.86 | 3.3 | 5.78 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.316 | -1.13 | 1.86 | 3.37 | 4.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.316 | -1.13 | 1.86 | 3.37 | 4.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.316 | -1.13 | 1.86 | 3.37 | 4.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.002 | -0.015 | 0.024 | 0.043 | 0.056 |